Dr. Martens (LON:DOCS) Stock Price Down 9.6% – What’s Next?

by · The Cerbat Gem

Dr. Martens plc (LON:DOCS – Get Free Report) fell 9.6% on Thursday . The company traded as low as GBX 72.30 and last traded at GBX 73.80. 4,733,644 shares traded hands during trading, an increase of 115% from the average session volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.

Analyst Upgrades and Downgrades

Separately, Peel Hunt restated a “buy” rating on shares of Dr. Martens in a report on Thursday. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, Dr. Martens presently has an average rating of “Hold” and a consensus price target of GBX 6,000.

Get Our Latest Stock Analysis on Dr. Martens

Dr. Martens Stock Down 0.7%

The stock has a fifty day simple moving average of GBX 89.93 and a two-hundred day simple moving average of GBX 80.44. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27. The firm has a market cap of £707.84 million, a PE ratio of 146.50, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS – Get Free Report) last released its quarterly earnings results on Thursday, November 20th. The company reported GBX (0.90) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. As a group, sell-side analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Insider Activity

In other Dr. Martens news, insider Giles Wilson sold 30,000 shares of the firm’s stock in a transaction on Monday, September 1st. The shares were sold at an average price of GBX 91, for a total value of £27,300. Also, insider Ije Nwokori sold 298,675 shares of the stock in a transaction dated Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total transaction of £268,807.50. Over the last 90 days, insiders have purchased 136,960 shares of company stock valued at $12,460,163 and have sold 434,460 shares valued at $39,131,400. Corporate insiders own 2.80% of the company’s stock.

About Dr. Martens

(Get Free Report)

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

Read More